The department receives grants for LC-MS
The Department of immunotechnology, with Sofia Waldermarson, Sara EK and Fredrik Levander as the main applicants, has received SEK 1 million from Medicon Village owner foundation, Mats Paulssons Research, Innovation and Societal Development fund, SEK 1 million from the “Stiftelsen Stefan Paulssons cancerfond” and SEK 4 million from LTH for a new liquid chromatography (LC) mass spectrometry (MS) system. This joint funding of a new mass spectrometer will enable researchers at the Department of Immuntechnology, as well as researchers at other departments at Lund University and members of Medicon Village to accelerate their discoveries of biomarkers for disease. With this new much more sensitive MS system, researchers will be able to detect low abundant proteins in clinical samples, such as plasma and tumour biopsies. This MS equipment also uses smaller samples volumes, saving clinical material for other analysis methods. The investment in this new equipment will also enable new collaborations between industry and academia at Medicon Village.
Welcome to the seminar
Immunotoxicity testing in the 21th century – recent developments within prediction of immunotoxicity using alternative methods.
The seminar will take place at the Medicon Village Aula (Hörsalen) on
November 23, 2017
Prof. Malin Lindstedt, Dept. of Immunotechnology
Kerstin Jakobsson, Vice President, Medicon Village
13.30-14.00 From pathways to people: applying the skin sensitization adverse outcome pathway (AOP)
Dr. Gavin Maxwell, Unilever's Safety & Environmental Assurance centre, UK
14.00-14.30 Towards an AOP for chemical respiratory allergy
Prof. Ian Kimber, University of Manchester, UK
15.00-15.30 Application of novel in vitro methods for the discovery of safe innovative medicines
Dr Jorrit Hornberg, Discovery Safety at AstraZeneca
15.30-16.00 Application of the AOP concept to structure the available in vivo and in vitro mechanistic data for allergic sensitization to food proteins
Dr Erwin Roggen, 3Rs Management and Consulting ApS
16.00-16.30 Progress towards GARDskin validation and GARDair implementation
Dr Henrik Johansson, SenzaGen AB
Please register before Nov 15 to firstname.lastname@example.org
SSF's utilization price
Malin Lindstedt, Professor of Immunoscientist Insitute, is the second prize winner of the Foundation for Strategic Research Award for Researchers. The prize goes to the researcher who showed his greatest commitment and had the highest innovation lelvel in their research. Malin Lindstedt has developed a series of tests under the name GARD, including "GARDpotency", which is used to predict the level of allergenicity for chemicals. This is of great importance for risk assessment of chemicals in, for example, the cosmetics industry. Malin research is behind seven patents and she is one of the founders of the company SenzaGen AB. The company currently has 14 employees and has also established a subsidiary in the US to reach the US market.
New Thinker Award 2017
Malin Lindstedt, Professor of Immunology at Lund University, has been awarded the New Thinker Award and SEK 400,000 from the Swedish Fund for Research Without Animal Experiments.
Professor Malin Lindstedt is awarded the prize for her work "with advanced methods continuing to reduce and replace the use of animals in risk assessment of chemicals and consumer products".
Biotech builder award to Professor Carl Borreback
Carl Borrebaeck, Professor at Department of immunotechnology, has been granted the prestigious BiotechBuilders Award for his pioneering medical research and role as entrepreneur within Life Science as co-founder to SanzaGen, Immunovia, Alligator Bioscience and BioInvent. The award was given at the annual BiotechBuilders event in Stockholm the 28th of August 2017. Through his commitment in SenzaGen, Carl Borrebaeck has contributed to the development of GARD – a gene based test for evaluation of chemical substances with allergenic properties, which reduce the need for animal testing.
Carl Borrebaeck received the BiotechBuilders Award with the motivation that he is a successful multi-entrepreneur who has contributed to the creation of numerous new life science companies, including Alligator Bioscience, Immunovia, BioInvent and SenzaGen. Also, his efforts in building scientific networks, among others Medicon Village, NOME(Nordic Mentor Network for Entrepreneurship) and Cancer Crosslink Conference, his position as a successful ”biotech builder“ makes him a valued representative figure for the Swedish Life Science industry.
Dr. Kristina Lundberg was appointed Associate Professor (docent) in Immunotechnology at Lund University.
The Call for the Canfaster is now open for application
February 17, 2017
Prof. Sara Ek of the Dept. of Immunotechnology heads a recently granted project entitled The translational cancer faster forward doctoral programme - CanFaster that received €1.6 M to partly fund 16 PhD students through the Marie Sklodowska-Curie action Co-funding of regional, national and international programmes (COFUND). (additional information in Swedish)
December 6, 2016
Dr. Sofia Waldemarson was appointed Associate Professor (docent) in Immunotechnology at Lund University.
November 15, 2016
Prof Sara Ek of the Dept. of Immunotechnology was awarded a grant from Cancerfonden for a project entitled Molekylära undersökningar av primära, resistenta och återfallstumörer hos patienter med mantelcellslymfom samt utveckling av kliniska verktyg för behandlingsval.
October 27, 2016
Prof. Mats Ohlin of the Dept. of Immunotechnology was awarded a grant from the Swedish Research Council for a project entitled "Molecular and functional analysis of IgE in allergy".
April 21, 2016
Malin Lindstedt was appointed professor of Immunotechnology at Lund University. Congratulations!
December 16, 2015
The Swedish Foundation for Strategic Environmental Research (MISTRA) will fund a second phase of the Mistra Biotech program. The program is hosted by the Swedish University of Agricultural Sciences and deeply involves Assoc Prof. Fredrik Levander of the Dept. of Immunotechnology.
November 3, 2015
Researchers in Stockholm, Uppsala, Linköping and Lund, including Prof. Carl Borrebaeck of the Dept. of Immunotechnology today argued in favor of more increased funding for development of personalized medicine in Sweden
November 1, 2015
Prof. Sara Ek today took office as Department Head of the Dept. of Immunotechnology.
October 15, 2015
MSc Andy Forreryd of the Dept. of Immunotechnology won 4500 sek for best free oral presentation at the SSCT-Swetox workshop with his presentation entitled Prediction of chemical respiratory sensitizers using GARD, a novel in vitro assay based on a genomic biomarker signature.
October 9, 2015
Rogosin Institute (New York, NY, USA) has signed an agreement with MAD for Cancer, a program headed by Prof. Carl Borrebaeck of the Dept. of Immuntechnology, to fund research Prof. Peter James of the Dept. of Immunotechnology.
October 8, 2015
Sara Ek was appointed professor of Immunotechnology at Lund University. Congratulations!
August 31, 2015
The European Spallation Source (ESS) today announced its first successful user collaboration for protein structure determination using neutron crystallography, carried out between Prof. Mats Ohlin of the Dept. of Immunotechnology and Dr. Zoë Fisher of ESS. The structure, which represents the first neutron crystal structure of a member of the large set of carbohydrate bindning modules (CBM) in complex with its carbohydrat ligand, has subsequently been published.
June 9, 2015
Andy Forreryd of the Dept. of Immunotechnology won a "Best Abstract Presentation Price" at the Oral Abstract session entitled Risk factors and biomarkers in occupational allergy held at EAACI 2015 in Barcelona. Andy's contribution was entitled Prediction of chemical respiratory sensitizers using GARD, a novel in vitro assay based on a genomic biomarker signature.
May 28, 2015
U-READ, the Unit for Rapid Engineered Antibody Development, at the Department of Immunotechnology was today accepted as an integrated part of SciLifeLab's Drug Discovery and Development platform (press release).
May 14, 2015
Prof. Mats Ohlin was today awarded a grant from the National Institute of Health through a project entitled Antigenic determinants of asthma-associated allergens for design of immunotherapy headed by Dr. Anna Pomés (INDOOR Biotechnologies Inc.).
May 13, 2015
Prof. Christer Wingren was awarded the distinction of Excellent Teaching Practitioner by the Lund School of Technology and he was accepted as member of the School's Pedagogic Academy.
December 15, 2014
Prof. Mats Ohlin was granted 2.5 MSEK by the Swedish Foundation for Strategic Research to support an industrial PhD student program entitled Target and antibody drug discovery in cancer in collaboration with BioInvent Int. AB.
November 3, 2014
Prof. Peter James was awarded 3.2 MSEK by the Swedish Research Council for a project entitled Analysis of post-translational modifications of membrane proteins.
October 30, 2014
Assoc. Prof. Malin Lindstedt was awarded 2.4 MSEK by the Swedish Research Council for a project entitled Vidareutveckling av GARD, ett alternativt cell-baserat test, med fokus på prediktion av irriterande substanser och potens av hudsensibiliserande kemikalier.
September 8, 2014
The Faculty of Technology at Lund University will fund a postdoctoral position within the area of RNA sequencing-assisted quantitative proteomics. The project will be hosted in the computational proteomics group headed by Assoc. Prof. Fredrik Levander.
June 17, 2014
Assoc. Prof. Malin Lindstedt of the Dept. of Immunotechnology was today awarded a grant of 6 MSEK from the Swedish Foundation for Strategic Research for a project entitled Prediction of sensibilisation by a cell-based assay system.
June 8, 2014
Dr. Mattias Levin of the Dept. of Immunotechnology today won the prize for best poster in the Allergic immune responses session at the 2014 European Academy of Allergy and Clinical Immunology Congress in Copenhagen. The titel of his work was Genetically restricted local IgE repertoires from nasal tissue of allergic donors target multiple epitopes on Bet v 1.
June 7, 2014
Dr. Kristina Lundberg of the Dept. of Immunotechnology today won the prize for best poster in the Immunotherapies & miscellaneous session at the 2014 European Academy of Allergy and Clinical Immunology Congress in Copenhagen. The titel of her work was Expression of allergy-associated C-type lectin receptors by DC subsets is modified by allergen-specific immunotherapy.
May 22, 2014
Christer Wingren was appointed Professor of Immunotechnology at Lund University. Congratulations!
January 23, 2014
The Lund University Cancer Center seminar series that aims at facilitating cancer research activities at Lund University and beyond kicks off today. During spring semester it will among others feature presentations by Christer Wingren, Peter James and Carl Borrebaeck from the Department of Immunotechnology.
December 17, 2013
Assoc. Prof. Malin Lindstedt has been awarded 2 MSEK from AFA Försäkring for a project entitled New test system for sensitizing chemicals.
November 19, 2013
Senior investigators at the Dept. of Immunotechnology presented their research at the Cancer Research Open House day arranged to present cancer research activities within Lund University departments located at Medicon Village.
November 5, 2013
Assoc. Prof. Sara Ek was awarded a grant from the Swedish Cancer Society for a project entitled "Beyond SOX11 – biological insight and development of a primary cell-based method for screeing of new pharmaceuticals targeting mantle cell lymphoma".
November 4, 2013
Assoc. Prof Christer Wingren has been granted support (5 MSEK) by the Swedish Research Council for a project entitled "Molecular profiling of systemic lupus erythematosus for better differential diagnosis and prognosis".
A European FP7 research grant has been awarded to a consortium that includes Prof. Peter James of the Dept. of Immunotechnology. The reBIRTH (Brain Imaging Return To Health) consortium is a Marie Curie Initial Training Network that gathers experts on molecular mechanisms of age-associated pathologies including neurodegeneration and depression. The group consists of seven universities, two private companies and one non-profit research organisation from 7 European countries. They work together to identify stress-regulated molecules provoking neuronal death and hindering neurogenesis, and monitor the consequences of these processes in human brain using advanced imaging techniques. Prof. James receives 6.4 MSEK and will be taking on three PhD students during the next three months.
September 27, 2013
The Department of Immunotechnology is moving to a new site! By the end of May, 2013 you will find us at Medicon Village (Building 406), Scheelevägen 2, S-223 63 Lund, Sweden.
Postal address: Dept. of Immunotechnology, Lund University, Medicon Village (Building 406), S-223 81 LUND, Sweden
November 30, 2012
Dr. Johan Malmström of the Dept. of Immunotechlogy was awarded a Wallenberg Academy Fellow grant (7.5 MSEK), a support form that provides long-term funding and enables the best researchers to focus their attention on their research, by the Knut and Alice Wallenberg Foundation.
November 1, 2012
The Department was granted support (a total of 9 MSEK) for four research projects by the Swedish Research Council:
- Prof. Carl Borrebaeck: Global proteome analysis based on group-specific antibodies and mass spectrometry.
- Assoc. prof. Malin Lindstedt: Prediction of compounds that cause sensibilisation of airways and skin using an alternative cell-based test system.
- Dr. Johan Malmström: PPSIMS: Mass spectrometric analysis of protein-protein interactions on the bacterial surface.
- Assoc. prof. Christer Wingren: Next generation antibody-based micromatrices for focused and global analysis of protein expression patterns and functional properties.
October 23, 2012
Prof. Carl Borrebaeck of the Dept. of Immunotechnology has been awarded the Royal Swedish Academy of Engineering Sciences' Gold Medal for his fundamental and pioneering research in applied immunology.
September 18, 2012
Prof. Carl Borrebaeck of the Dept. of Immunotechnology has been granted the annual reward by the independent Research!Sweden (Forska!Sverige) Foundation for his research in medicine and his entrepreneurship.
September 10, 2012
Dr. Johan Malmström has received an ERC starting grant amounting to 1.5 million € from the European Science Council for his proteomics research on Streptococci in terms of a project entitled "In vivo pathogen profiling using selected reaction monitoring".
May 31, 2012
Dr. Anders Carlsson of the Dept. of Immunotechnology was awarded the Gina Prize for the best clinical/translational research article published during 2011 within BioCARE, a strategic cancer research program run by Lund University and University of Gothenburg.
The prize was awarded for the findings reported in:
Carlsson et al. (2011) Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases PNAS 108, 14252-14257 (Abstract).
Assoc. Prof. Malin Lindstedt was awarded 2 MSEK from VINNOVA for a project to investigate a cell based assay system for prediction of allergenicity.
December 15, 2011
Prof. Mats Ohlin was awarded a grant of 4.7 MSEK for an antibody engineering project from the Swedish National Space Board.
December 9, 2011
Paolo Cinfani of the Dept. of Immunotechnology won the 2011 Create Health Science Slam with a presentation entitled: "Cancer proteomics: a racist approach".
Johan Teleman of the Dept. of Immunotechnology was awarded a price for best MSc thesis in 2011 from the Bo Rydin Foundation for Scientific Research.
December 1, 2011
Prof. Carl Borrebaeck was awarded a 9 MSEK grant from VINNOVA for the project CREATE Health - a translational cancer center.
November 14, 2011
Doc. Malin Lindstedt has been granted support (7.08 MSEK during 2012-2015) for a research project entitled "A novel test strategy for assessing sensitizing capacity of chemicals and proteins" by FORMAS.
November 7, 2011
The Department was granted support for two research projects by the Swedish Research Council:
- Doc. Sara Ek: Deciphering the molecular mechanisms of SOX11-related tumor growth.
- Prof. Mats Ohlin: Human monoclonal IgE - addressing clinical aspects in allergy using molecular tools.
June 15, 2011
M.Sc. Henrik Johansson and M.Sc. Mattias Levin, doctoral students at the Department of Immunotechnology, were both awarded with presentation prizes at the 30th Congress of the European Academy of Allergy and Clinical Immunology held in Istanbul, Turkey.
June 1, 2011
Dr. Kristina Lundberg received a grant of 1 MSEK for a project entitled ”Development of effective treatment strategies in allergy" from Signhild Engkvist Stiftelse
March 4, 2011
Dr. Elin Gustavsson, a former PhD student at the Dept. of Immunotechnology, was awarded a price for best thesis conducted within the framework of the CREATE Health strategic center for translational cancer research during 2009-2010.
February 19, 2011
The Breast Cancer Initiative, a part of the interdisciplinary cancer centre Create Health headed by Prof. Carl Borrebaeck of the Dept. of Immunotechnology, was awarded 25 MSEK from the Swedish innovation agency Vinnova.
December 12, 2010
Dr. Johan Malmström of the Dept. of Immunotechnology has been awarded 10 MSEK by the Swedish Foundation for Strategic Research as part of their Future Research Leaders programme for his research on virulence mechanisms in Streptococci.
December 6, 2010
Dr. Malin Lindstedt, Dr. Kristina Lundberg, M.Sc. Henrik Johansson, M.Sc. Anna Sandström och M.Sc. Mattias Levin of the Dept. of Immunotechnology were awarded 129 kSEK in travel grants from the Faculty of Engineering at Lund University.
November 5, 2010
The Department was granted support for two research projects by the Swedish Research Council:
- Prof. Peter James: Analysis of membrane proteins
- Doc. Christer Wingren: Molecular profiling of systemic lupus erythematosus for improved diagnosis, classification and prognosis
October 8, 2010
The Department celebrated the
20th anniversary of the inauguration of Immunotechnology at Lund University.
Dr. Christer Wingren of the Dept. of Immunotechnology is a partner in the new Phast-ID project supported by a grant from the EU 7th framework programme that will develop a photonic crystal-based disposable biosensor for use in point-of-care diagnostic applications.
May 28, 2010
Johan Malmström at the Dept. of Immunotechnology has been granted 3.4 MSEK from the Crafoord Foundation.
April 1, 2010
The EU FP7-funded collaborative project AFFINOMICS - Protein Binders for Characterization of Human Proteome Function: Generation, Validation, Application commenced its operation. The Department of Immunotechnology is one of 15 partners from Sweden, Switzerland, Denmark, Finland, Germany, Italy, UK and Belgium.
March 24, 2010
Lund University and the Faculty of Engineering granted the Dept. of Immunotechnology funding for a postdoctoral position that is to be held by Dr. Kristina Lundberg.
February 9, 2010
Dr. Fredrik Levander has been appointed Associate Professor (docent) at the Department of Immunotechnology.
BioCARE, a center within the Swedish Research Council's effort to support strategic research areas, has been inaugurated. Prof. Carl Borrebaeck, the head of the Dept. of Immunotechnology, is one of 10 principal investigators active within this center. It will focus its activities to the field of biomarkers in cancer medicine.
Assoc. Prof. Sara Ek was awarded a grant (1 MSEK) from Stiftelsen Olle Engkvist Byggmästare for a project entitled "Development of therapeutic modalities based on novel transcription factors, including Sox 11".
December 17, 2009
Dr. Fredrik Levander of the Dept. of Immunotechnology is one of three principal investigators in a concortium (lead by Professor Erik Andreasson at the Swedish University of Agricultural Sciences) that has been awarded a framework project grant amounting to 20 MSEK from the Swedish Foundation for Strategic Research to investigate late blight disease in potato.
October 29, 2009
September 9, 2009
Dr. Malin Lindstedt was granted support for a research project on alternative methods that do not require laboratory animals for allergen testing by the Swedish Research Council.
September 1, 2009
Dr. Fredrik Levander has been appointed to coordinate proteomics data handling on a nation-wide level within the Bioinformatics Infrastructure for Life Sciences (BILS).
June 15, 2009
A consortium, which includes the Dept. of Immunotechnology, has been recommended to receive 64 MSEK during 2010-2014, for a project entitled "BioCARE - Biomarkers in Cancer Medicine Improving Health Care, Education and Innovation" as part of the government's allocation of resources to strategic research areas.
June 8, 2009
Prof. Carl Boorebaeck has received a grant (5 MSEK) from Vinnova to develop an affinity proteomics platform into a discovery tool
March 31, 2009
The strategic translational research centre CREATE Health, administered by the Department of Immunotechnology, received 10 MSEK as additional funding for its final 2 years.
March 17, 2009
The Department of Immunotechnology is expanding. Mattias Levin, Frida Pauly, Linn Petersson, Zahra El-Schish and Marianne Sandin have therefore recently joined the department.
March 1, 2009
The head of the Dept. of Immunotechnology, Prof. Carl Borrebaeck, was awarded the AkzoNobel Science Award Sweden 2009 for his groundbreaking translational research and its transfer into practical use.
January 29, 2009
The head of the Dept. of Immunotechnology, Prof. Carl Borrebaeck, was appointed Assistant Vice-Chancellor of Lund University. He will focus on the University's innovation strategies.
November 13, 2008
The Department was granted support for a research project by the Swedish Cancer Society
- Sara Ek: Evaluation of Sox11 as therapeutic target in B cell lymphomas and analysis of its functional properties in malignant cells.
November 4-5, 2008
The Department was granted support for several research projects by the Swedish Research Council:
- Carl Borrebaeck: Cellular basis for allergy: regulation of the allergic immune response by dendritic cells
- Carl Borrebaeck: Global proteome analysis using context independent motif specific antibodies and micoarrays
- Mats Ohlin: Allergen-specific antibodies of IgE class in nasal mucosa
- Peter Ellmark: Development of immuno-nanoparticles for cancer therapy
Sept 17, 2008
The Department of Immunotechnology's research has been assessed as being "Excellent-Outstanding" in the University's research quality assessment programme RQ08.
Dr Sara Ek and Prof Carl Borrebaeck received a grant from the Leukemia & Lymphoma Society for a study of mantle cell lymphoma.
May 27-28, 2008
Researchers at the Department were granted postdoctoral research grants by the Swedish Research Council
- Dr. Helena Persson: Synthetic antibodies for functional and structural characterization of membrane proteins. She will go to the University of Toronto, Canada
- Dr. Sofia Waldemarsson: Proteomic profiling of lung cancer for discovery and verification of novel prognostic and diagnostic biomarkers
May 20, 2008
Prof. Mats Ohlin was awarded the distinction of Excellent Teaching Practitioner by the Lund School of Technology and he was accepted as member of the School's Pedagogic Academy.
Dr. Christer Wingren received a grant from Vinnova to develop a microchip technology platform for cancer diagnosis.
The Department was granted a 2 year postdoctoral grant for Dr. Helena Persson from the Lund School of Technology.
Oct 31-Nov 13, 2007
The Department was granted support for several research projects by the Swedish Research Council:
- Fredrik Levander: Analysis platform for mass spectrometry-based proteome comparison
- Peter James: Quantitative whole and targeted proteome monitoring
- Peter James: Breast cancer proteomics
- Christer Wingren: Programmed self-assembly of antibody arrays interfaced with label-free sensing: novel opportunities for high-throughput proteomics
Dr. Malin Lindstedt and Prof. Carl Borrebaeck were awarded a grant from Vinnova for a project entitled "Utveckling av ny vaccinprincip baserad på intracellulär antigenfrisättning från nanopartiklar"
March 13, 2007
The Knut and Alice Wallenberg Foundation granted a consortium at Lund University headed by the Department of Immunotechnology 25 MSEK to fund acquisition of equipment for use in genomic and proteomic studies of cancer.
January 1, 2007
The Dept. of Immunotechnology was formed after a merger of the Division of Immunotechnology (formerly at the Department of Chemistry) and the Division of Protein Technology (formerly at the Department of Electrical Measurements).